Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
The Role of Sel1L and ER Quality Control in Adipocytes
Cornell University Veterinary Investigator Program
CNS Sites Mediating Cognition and Mood: Impact of Apnea
Biochemical Modulation with Transport Inhibitors
Recently added grants:
Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder
Biomarker Candidates in Gulf War Veterans: A 10-year Follow-up Investigation
Optimal Treatment of Veterans with PTSD and Comorbid Opiate Use Disorder (OUD)
The Epidemiology and Economics of Chronic Back Pain
Molecular function of Myosin-l
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA074665-01A1S1
Application #
6021665
Study Section
Special Emphasis Panel (ZRG2 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant